BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20471695)

  • 1. Earliest functional declines in Huntington disease.
    Beglinger LJ; O'Rourke JJ; Wang C; Langbehn DR; Duff K; Paulsen JS;
    Psychiatry Res; 2010 Jul; 178(2):414-8. PubMed ID: 20471695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of functional decline in Huntington's disease. Huntington Study Group.
    Marder K; Zhao H; Myers RH; Cudkowicz M; Kayson E; Kieburtz K; Orme C; Paulsen J; Penney JB; Siemers E; Shoulson I
    Neurology; 2000 Jan; 54(2):452-8. PubMed ID: 10668713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unified Huntington's disease rating scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Oct; 28(12):1717-23. PubMed ID: 24166899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.
    Vaccarino AL; Anderson K; Borowsky B; Duff K; Giuliano J; Guttman M; Ho AK; Orth M; Paulsen JS; Sills T; van Kammen DP; Evans KR;
    Mov Disord; 2011 Apr; 26(5):877-84. PubMed ID: 21370269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Beglinger LJ; Duff K; Allison J; Theriault D; O'Rourke JJ; Leserman A; Paulsen JS
    J Clin Exp Neuropsychol; 2010 Jul; 32(6):573-8. PubMed ID: 19882420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of Huntington disease.
    Dorsey ER; Beck CA; Darwin K; Nichols P; Brocht AF; Biglan KM; Shoulson I;
    JAMA Neurol; 2013 Dec; 70(12):1520-30. PubMed ID: 24126537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unified Huntington's disease rating scale: clinical practice and a critical approach.
    Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
    Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease.
    Zielonka D; Ren M; De Michele G; Roos RAC; Squitieri F; Bentivoglio AR; Marcinkowski JT; Landwehrmeyer GB
    Parkinsonism Relat Disord; 2018 Apr; 49():42-47. PubMed ID: 29326033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of simple movements and progression of Huntington's disease.
    Andrich J; Saft C; Ostholt N; Müller T
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):405-7. PubMed ID: 17369593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unawareness of motor phenoconversion in Huntington disease.
    McCusker EA; Gunn DG; Epping EA; Loy CT; Radford K; Griffith J; Mills JA; Long JD; Paulsen JS;
    Neurology; 2013 Sep; 81(13):1141-7. PubMed ID: 23966256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross-sectional study.
    Migliore S; D'Aurizio G; Maffi S; Ceccarelli C; Ristori G; Romano S; Castaldo A; Mariotti C; Curcio G; Squitieri F
    Brain Behav; 2021 Jul; 11(7):e02151. PubMed ID: 34110097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
    Fragassi NA; Stanzione M; Angelini R; Di Maio L
    Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysphagia in Huntington's Disease: Correlation with Clinical Features.
    de Tommaso M; Nuzzi A; Dellomonaco AR; Sciruicchio V; Serpino C; Cormio C; Franco G; Megna M
    Eur Neurol; 2015; 74(1-2):49-53. PubMed ID: 26183666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everyday cognition in prodromal Huntington disease.
    Williams JK; Kim JI; Downing N; Farias S; Harrington DL; Long JD; Mills JA; Paulsen JS;
    Neuropsychology; 2015 Mar; 29(2):255-67. PubMed ID: 25000321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and autonomic dysfunction in presymptomatic and early Huntington's disease.
    Kobal J; Melik Z; Cankar K; Strucl M
    J Neurol; 2014 Jun; 261(6):1119-25. PubMed ID: 24691902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising mobility outcome measures in Huntington's disease.
    Busse M; Quinn L; Khalil H; McEwan K
    J Huntingtons Dis; 2014; 3(2):175-88. PubMed ID: 25062860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of the Unified Huntington's Disease Rating Scale (UHDRS) and UHDRS-For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington's disease.
    Winder JY; Achterberg WP; Gardiner SL; Roos RAC
    Eur J Neurol; 2019 May; 26(5):780-785. PubMed ID: 30576046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assistive Technology for Cognition and Health-related Quality of Life in Huntington's Disease.
    van Walsem MR; Howe EI; Frich JC; Andelic N
    J Huntingtons Dis; 2016 Oct; 5(3):261-270. PubMed ID: 27689618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.